Literature DB >> 12057155

Pericardial mesothelioma.

W T Vigneswaran1, P R Stefanacci.   

Abstract

Primary pericardial mesothelioma is a rare but lethal disease. Altogether there are about 150 cases reported in the literature. In most cases the diagnosis is made at autopsy or postoperatively. Clinical signs and symptoms are typically nonspecific and are similar to compromised cardiac function. Surgical resection remains the main treatment modality. When the disease is localized and completely resected, long-term survival can result. Most often the tumor invades the myocardium or the great vessels and therefore is at best palliative in relieving pericardial tamponade or constriction. Addition of chemotherapy or radiation has been disappointing. Newer therapeutic approaches for malignant pleural mesothelioma are likely to influence the treatment of pericardial mesothelioma in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12057155     DOI: 10.1007/s11864-000-0045-6

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  20 in total

1.  Primary pericardial mesothelioma: one-year event-free survival.

Authors:  C A Nambiar; H E Tareif; K U Kishore; J Ravindran; A K Banerjee
Journal:  Am Heart J       Date:  1992-09       Impact factor: 4.749

2.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Authors:  D J Sugarbaker; R M Flores; M T Jaklitsch; W G Richards; G M Strauss; J M Corson; M M DeCamp; S J Swanson; R Bueno; J M Lukanich; E H Baldini; S J Mentzer
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

3.  A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.

Authors:  H W Pass; B K Temeck; K Kranda; S M Steinberg; H I Pass
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

4.  Magnetic resonance imaging findings in a patient with pericardial mesothelioma.

Authors:  H D Gössinger; P Siostrzonek; M Zangeneh; A Neuhold; C Herold; R Schmoliner; A Laczkovics; D Tscholakoff; H Mösslacher
Journal:  Am Heart J       Date:  1988-06       Impact factor: 4.749

Review 5.  Primary malignant pericardial mesothelioma: a case report and review.

Authors:  T K Kaul; B L Fields; D R Kahn
Journal:  J Cardiovasc Surg (Torino)       Date:  1994-06       Impact factor: 1.888

6.  Meningeal and brain metastases in primary malignant pericardial mesothelioma.

Authors:  U Bohn; J L Gonzalez; L M Martin; A Casado; E Diaz-Rubio; P Aragoncillo
Journal:  Ann Oncol       Date:  1994-09       Impact factor: 32.976

7.  Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene.

Authors:  W R Smythe; H C Hwang; A A Elshami; K M Amin; S L Eck; B L Davidson; J M Wilson; L R Kaiser; S M Albelda
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

8.  Malignant mesothelioma arising after direct application of asbestos and fiber glass to the pericardium.

Authors:  A Churg; M L Warnock; K G Bensch
Journal:  Am Rev Respir Dis       Date:  1978-08

9.  Primary pericardial mesothelioma detected by gallium-67 scintigraphy.

Authors:  T Nishikimi; H Ochi; K Hirota; Y Ikuno; H Oku; K Takeuchi; T Takeda
Journal:  J Nucl Med       Date:  1987-07       Impact factor: 10.057

10.  Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.

Authors:  A P Chahinian; K Antman; M Goutsou; J M Corson; Y Suzuki; C Modeas; J E Herndon; J Aisner; R R Ellison; L Leone
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

View more
  6 in total

1.  Malignant pericardial mesothelioma : A systematic review of current practice.

Authors:  S Cao; S Jin; J Cao; J Shen; H Zhang; Q Meng; B Pan; Y Yu
Journal:  Herz       Date:  2017-01-27       Impact factor: 1.443

2.  Primary malignant pericardial mesothelioma with increased serum mesothelin diagnosed by surgical pericardial resection: A case report.

Authors:  Takeyuki Kurosawa; Keishi Sugino; Kazutoshi Isobe; Yoshinobu Hata; Yuri Fukasawa; Sakae Homma
Journal:  Mol Clin Oncol       Date:  2016-09-15

Review 3.  Primary and secondary cardiac tumors: clinical presentation, diagnosis, surgical treatment, and results.

Authors:  Alessio Campisi; Angelo Paolo Ciarrocchi; Nizar Asadi; Andrea Dell'Amore
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-01-09

4.  Malignant mesothelioma of the pericardium: a report of two different presentations.

Authors:  Pattarapong Makarawate; Narumol Chaosuwannakit; Jarin Chindaprasirt; Piti Ungarreevittaya; Surachat Chaiwiriyakul; Kosin Wirasorn; Chusak Kuptarnond; Kittisak Sawanyawisuth
Journal:  Case Rep Oncol Med       Date:  2013-08-21

5.  Malignant Pericardial Mesothelioma Treated Using Volumetric Modulated Arc Therapy With a Simultaneous Integrated Boost.

Authors:  Cole Steber; Joshua Farris; Ryan T Hughes; Corbin A Helis; Tawfeq Naal; Jung W Kim-Shapiro; Travis Jacobson; Michael K Farris
Journal:  Adv Radiat Oncol       Date:  2020-09-22

Review 6.  Cardiac Tumors: Diagnosis, Prognosis, and Treatment.

Authors:  Rossana Bussani; Matteo Castrichini; Luca Restivo; Enrico Fabris; Aldostefano Porcari; Federico Ferro; Alberto Pivetta; Renata Korcova; Chiara Cappelletto; Paolo Manca; Vincenzo Nuzzi; Riccardo Bessi; Linda Pagura; Laura Massa; Gianfranco Sinagra
Journal:  Curr Cardiol Rep       Date:  2020-10-10       Impact factor: 2.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.